Goldman Sachs Group »

Aim Immunotech shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Aim Immunotech

Tip: Access up to 7 years of quarterly data

All positions including Aim Immunotech held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aim Immunotech by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.2k 32k 0.28

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
State Str Spdr S&p 500 Etf T CMN (SPY)
Apple CMN (AAPL)
Micron Technology CMN (MU)
Microsoft Corp CMN (MSFT)
Taiwan Semiconductor Manufac CMN (TSM)
Alphabet CMN (GOOGL)
Sandisk Corp CMN (SNDK)
Amazon CMN (AMZN)
Invesco Qqq Tr CMN (QQQ)
Broadcom CMN (AVGO)
Vaneck Etf Trust CMN (SMH)
Tesla CMN (TSLA)
Meta Platforms CMN (META)
Alphabet CMN (GOOG)

View all positions for Goldman Sachs Group

Top funds holding Aim Immunotech

Jane Street
Virtu Financial
Geode Capital Management
Goldman Sachs Group
UBS Group
Susquehanna International
Vanguard Fiduciary Trust
Ground Swell Capital
Tower Research Capital
Morgan Stanley
Continuum Advisory
Community Bank
Harbour Investments
Creative Financial Designs
Advisor Group Holdings

View all funds holding Aim Immunotech